Raludotatug deruxtecan Antibody
Raludotatug deruxtecan (DS-6000) is a CDH6-targeting antibody-drug conjugate (ADC) developed for cancer research, with a focus on ovarian cancer. Preclinical studies demonstrate its anti-tumor activity in both in vitro assays and in vivo xenograft models, supporting its investigation as a potential therapeutic.
Product Specifications
Product Name Alternative
DS-6000, DS-6000a, MK5909, MK-5909, R-DXd
Target
ADC Antibody
Clonality
Recombinant
Conjugation
Unconjugated
Concentration
4.94 mg/mL
Purity
98.14% (May vary between batches)
Molecular Weight
145.54 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog